3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)-

3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Struktur
1805833-75-3
CAS-Nr.
1805833-75-3
Englisch Name:
3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)-
Synonyma:
CT7001);PPDA-001;ICEC-0942;Samuraciclib;ICEC 0942 (ICEC0942;Samuraciclib (CT7001;ICEC0942 (CT7001) Free base;Samuraciclib (Synonyms: CT7001;(3R,4R)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-ol;3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)-
CBNumber:
CB73362078
Summenformel:
C22H30N6O
Molgewicht:
394.51
MOL-Datei:
1805833-75-3.mol

3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Eigenschaften

Dichte
1.30±0.1 g/cm3(Predicted)
pka
14.69±0.40(Predicted)

Sicherheit

3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Samuraciclib can be used to treat tuberous sclerosis complex using cyclin dependent kinase 7 (CDK7) inhibitors.

3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 15)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226
sales@hzclap.com CHINA 6313 58
Cool Pharm, Ltd 021-60455363 18019463053
sales@coolpharm.com China 12357 58
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
TaiChem Taizhou Limited 052386810091
zcwy9518@yeah.net China 3875 58
Shanghai Biopharmaleader Co., Ltd. +86 18721201413
sales@biopharmaleader.com China 1720 58
Jiangsu yize medical technology co. LTD 18962082606
3394205705@qq.com China 1751 58
Changzhou Yongfeng Biomedicine Co. Ltd. 15006117673
2973592490@qq.com China 310 58
Wuhan Ruilida Biomedical Technology Co., Ltd. 18201884268
magean83@163.com China 1317 58
DC Chemicals 021-58447131 13564518121
sales@dcchemicals.com China 9412 58

  • 3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)-
  • PPDA-001
  • ICEC0942 (CT7001) Free base
  • ICEC-0942
  • CT7001)
  • ICEC 0942 (ICEC0942
  • Samuraciclib
  • (3R,4R)-4-(((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)methyl)piperidin-3-ol
  • Samuraciclib (Synonyms: CT7001
  • Samuraciclib (CT7001
  • 1805833-75-3
Copyright 2019 © ChemicalBook. All rights reserved